Previous close | 1.3500 |
Open | 1.3500 |
Bid | 0.0000 |
Ask | 2.8000 |
Strike | 120.00 |
Expiry date | 2024-12-20 |
Day's range | 1.3500 - 1.3500 |
Contract range | N/A |
Volume | |
Open interest | 21 |
SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2025 on Thursday, October 24, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Location: http://investor.resmed.com Date
Ferrari, Vertex, ResMed and Hubbel have been highlighted in this Screen of The Week article.
Fears that GLP-1 obesity drugs would reduce demand for ResMed’s various CPAP airflow machines have proven unfounded..